Suchergebnisse - "Yang, Jiao"

PubPharm (11)

1

Palbociclib plus endocrine therapy in hormone receptor-positive and HER2 negative metastatic breast cancer : a multicenter real-world study in the northwest of China

enthalten in: BMC cancer | 2023

von Yang, J. | Zhao, B. | Ling, X. | +7

2

Pathological characteristics and tumour immune microenvironment of lung malignancies with RET rearrangement

enthalten in: Cancer treatment and research communications | 2023

von Gao, Q. | Xiao, F. | Lin, X. | +10

3

Structural optimization and structure-activity relationship studies of N-phenyl-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-4-amine derivatives as a new class of inhibitors of RET and its drug resistance mutants

enthalten in: European journal of medicinal chemistry | 2018

von Yang, J. | Chen, K. | Zhang, G. | +14

4

SKLB188 inhibits the growth of head and neck squamous cell carcinoma by suppressing EGFR signalling

enthalten in: British journal of cancer | 2017

von Barzegar, M. | Ma, S. | Zhang, C. | +8

5

Potential biomarkers for anti-EGFR therapy in metastatic colorectal cancer

enthalten in: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine | 2016

von Yang, J. | Li, S. | Wang, B. | +5

6

Bifunctional αHER2/CD3 RNA-engineered CART-like human T cells specifically eliminate HER2(+) gastric cancer

enthalten in: Cell research | 2016

von Luo, F. | Qian, J. | Yang, J. | +4

7

A preclinical evaluation of SKLB261, a multikinase inhibitor of EGFR/Src/VEGFR2, as a therapeutic agent against pancreatic cancer

enthalten in: Molecular cancer therapeutics | 2015

von Pan, Y. | Zheng, M. | Zhong, L. | +6

8

Overexpression of CSF-1R in nasopharyngeal carcinoma

enthalten in: Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie | 2015

von Huang, L. | Xu, X. | Hao, Y. | +9

9

Structural optimization and structure-activity relationships of N2-(4-(4-Methylpiperazin-1-yl)phenyl)-N8-phenyl-9H-purine-2,8-diamine derivatives, a new class of reversible kinase inhibitors targeting both EGFR-activating and resistance mutations

enthalten in: Journal of medicinal chemistry | 2012

von Yang, J. | Wang, L. | Liu, J. | +10

10

Discovery of the novel potent and selective FLT3 inhibitor 1-{5-[7-(3- morpholinopropoxy)quinazolin-4-ylthio]-[1,3,4]thiadiazol-2-yl}-3-p-tolylurea and its anti-acute myeloid leukemia (AML) activities in vitro and in vivo

enthalten in: Journal of medicinal chemistry | 2012

von Li, W. | Wang, X. | Zheng, R. | +16